{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T15:29:08Z","timestamp":1795102148832,"version":"4.10.3"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Stichting Alzheimer Onderzoek","award":["20200034"],"award-info":[{"award-number":["20200034"]}]},{"name":"Stichting Alzheimer Onderzoek","award":["2020\/017"],"award-info":[{"award-number":["2020\/017"]}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2020.08750BD"],"award-info":[{"award-number":["2020.08750BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G0F8516N"],"award-info":[{"award-number":["G0F8516N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G065721N"],"award-info":[{"award-number":["G065721N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"name":"KU-Leuven Internal Funding","award":["C14\/17\/107"],"award-info":[{"award-number":["C14\/17\/107"]}]},{"name":"KU-Leuven Internal Funding","award":["C14\/22\/132"],"award-info":[{"award-number":["C14\/22\/132"]}]},{"name":"KU-Leuven Internal Funding","award":["C3\/20\/057"],"award-info":[{"award-number":["C3\/20\/057"]}]},{"name":"Bit Bio Ltd","award":["RRAG\/257"],"award-info":[{"award-number":["RRAG\/257"]}]},{"DOI":"10.13039\/100010269","name":"Welcome Trust","doi-asserted-by":"crossref","award":["RG86251"],"award-info":[{"award-number":["RG86251"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Open Targets","award":["OTAR2052"],"award-info":[{"award-number":["OTAR2052"]}],"id":[{"id":"https:\/\/ror.org\/000bp7q73","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["H2020 WIDESPREAD-2018-2020-6"],"award-info":[{"award-number":["H2020 WIDESPREAD-2018-2020-6"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["NCBio"],"award-info":[{"award-number":["NCBio"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["951923"],"award-info":[{"award-number":["951923"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["RRZA\/175"],"award-info":[{"award-number":["RRZA\/175"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"name":"VIB Tech Watch"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Parkinson\u2019s Disease (PD) is the second most common neurodegenerative disorder. The pathological hallmark of PD is loss of dopaminergic neurons and the presence of aggregated \u03b1-synuclein, primarily in the substantia nigra pars compacta (SNpc) of the midbrain. However, the molecular mechanisms that underlie the pathology in different cell types is not currently understood. Here, we present a single nucleus transcriptome analysis of human post-mortem SNpc obtained from 15 sporadic Parkinson\u2019s Disease (PD) cases and 14 Controls. Our dataset comprises \u223c84K nuclei, representing all major cell types of the brain, allowing us to obtain a transcriptome-level characterization of these cell types. Importantly, we identify multiple subpopulations for each cell type and describe specific gene sets that provide insights into the differing roles of these subpopulations. Our findings reveal a significant decrease in neuronal cells in PD samples, accompanied by an increase in glial cells and T cells. Subpopulation analyses demonstrate a significant depletion of tyrosine hydroxylase (\n                    <jats:italic>TH<\/jats:italic>\n                    ) enriched astrocyte, microglia and oligodendrocyte populations in PD samples, as well as\n                    <jats:italic>TH<\/jats:italic>\n                    enriched neurons, which are also depleted. Moreover, marker gene analysis of the depleted subpopulations identified 28 overlapping genes, including those associated with dopamine metabolism (e.g.,\n                    <jats:italic>ALDH1A1, SLC6A3 &amp; SLC18A2<\/jats:italic>\n                    ). Overall, our study provides a valuable resource for understanding the molecular mechanisms involved in dopaminergic neuron degeneration and glial responses in PD, highlighting the existence of novel subpopulations and cell type-specific gene sets.\n                  <\/jats:p>","DOI":"10.1186\/s13024-023-00699-0","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:02:17Z","timestamp":1705708937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":146,"title":["Unravelling cell type-specific responses to Parkinson\u2019s Disease at single cell resolution"],"prefix":"10.1186","volume":"19","author":[{"given":"Araks","family":"Martirosyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizwan","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Pestana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Hebestreit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayk","family":"Gasparyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razmik","family":"Aleksanyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Hnatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Poovathingal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Marneffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar R.","family":"Thal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kottick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor J.","family":"Hanson-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Guelfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Plumbly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Grant","family":"Belgard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2893-9741","authenticated-orcid":false,"given":"Emmanouil","family":"Metzakopian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8958-4027","authenticated-orcid":false,"given":"Matthew G.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,20]]},"reference":[{"key":"699_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/s0140-6736(21)00218-x","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397:2284\u2013303. https:\/\/doi.org\/10.1016\/s0140-6736(21)00218-x.","journal-title":"Lancet"},{"key":"699_CR2","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388:839\u201340. https:\/\/doi.org\/10.1038\/42166.","journal-title":"Nature"},{"issue":"4","key":"699_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3390\/biomedicines9040368","volume":"9","author":"SX Ma","year":"2021","unstructured":"Ma SX, Lim SB. Single-cell RNA sequencing in Parkinson\u2019s disease. Biomedicines. 2021;9(4):368. https:\/\/doi.org\/10.3390\/biomedicines9040368.","journal-title":"Biomedicines"},{"key":"699_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.stem.2018.10.023","volume":"24","author":"C Lang","year":"2019","unstructured":"Lang C, Campbell KR, Ryan BJ, Carling P, Attar M, Vowles J, et al. Single-cell sequencing of iPSC-Dopamine neurons reconstructs disease progression and identifies HDAC4 as a regulator of Parkinson cell phenotypes. Cell Stem Cell. 2019;24:93-106.e6. https:\/\/doi.org\/10.1016\/j.stem.2018.10.023.","journal-title":"Cell Stem Cell"},{"key":"699_CR5","doi-asserted-by":"publisher","unstructured":"Fernandes HJR, Patikas N, Foskolou S, Field SF, Park JE, Byrne ML, et al. Single-cell transcriptomics of Parkinson\u2019s disease human in vitro models reveals dopamine neuron-specific stress responses. Cell Rep. 2020;33(2):108263. https:\/\/doi.org\/10.1016\/j.celrep.2020.108263.","DOI":"10.1016\/j.celrep.2020.108263"},{"key":"699_CR6","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/brain\/awab446","volume":"145","author":"S Smaji\u0107","year":"2022","unstructured":"Smaji\u0107 S, Prada-Medina CA, Landoulsi Z, Ghelfi J, Delcambre S, Dietrich C, et al. Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain. 2022;145:964\u201378. https:\/\/doi.org\/10.1093\/brain\/awab446.","journal-title":"Brain"},{"key":"699_CR7","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1038\/s41467-020-17876-0","volume":"11","author":"D Agarwal","year":"2020","unstructured":"Agarwal D, Sandor C, Volpato V, Caffrey TM, Monz\u00f3n-Sandoval J, Bowden R, et al. A single-cell atlas of the human substantia nigra reveals cell-specific pathways associated with neurological disorders. Nat Commun. 2020;11:4183. https:\/\/doi.org\/10.1038\/s41467-020-17876-0.","journal-title":"Nat Commun"},{"key":"699_CR8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","volume":"25","author":"T Kamath","year":"2022","unstructured":"Kamath T, Abdulraouf A, Burris SJ, Langlieb J, Gazestani V, Nadaf NM, et al. Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson\u2019s disease. Nat Neurosci. 2022;25:588\u201395. https:\/\/doi.org\/10.1038\/s41593-022-01061-1.","journal-title":"Nat Neurosci"},{"key":"699_CR9","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.ajhg.2018.10.018","volume":"103","author":"SA McClymont","year":"2018","unstructured":"McClymont SA, Hook PW, Soto AI, Reed X, Law WD, Kerans SJ, et al. Parkinson-associated SNCA enhancer variants revealed by open chromatin in mouse dopamine neurons. Am J Hum Genet. 2018;103:874\u201392. https:\/\/doi.org\/10.1016\/j.ajhg.2018.10.018.","journal-title":"Am J Hum Genet"},{"key":"699_CR10","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.neurobiolaging.2013.11.001","volume":"35","author":"L Dunn","year":"2014","unstructured":"Dunn L, Allen GFG, Mamais A, Ling H, Li A, Duberley KE, et al. Dysregulation of glucose metabolism is an early event in sporadic Parkinson\u2019s disease. Neurobiol Aging. 2014;35:1111\u20135. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.11.001.","journal-title":"Neurobiol Aging"},{"key":"699_CR11","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.molcel.2014.12.040","volume":"57","author":"HM Genau","year":"2015","unstructured":"Genau HM, Huber J, Rogov V, Correspondence CB, Baschieri F, Akutsu M, et al. CUL3-KBTBD6\/KBTBD7 ubiquitin ligase cooperates with GABARAP proteins to spatially restrict TIAM1-RAC1 signaling. Mol Cell. 2015;57:995\u20131010. https:\/\/doi.org\/10.1016\/j.molcel.2014.12.040.","journal-title":"Mol Cell"},{"key":"699_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-cellbio-100818-125512","volume":"36","author":"PK Singh","year":"2020","unstructured":"Singh PK, Muqit MMK. Parkinson\u2019s: a disease of aberrant vesicle trafficking. Annu Rev Cell Dev Biol. 2020;36:237\u201364. https:\/\/doi.org\/10.1146\/annurev-cellbio-100818-125512.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"699_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1073\/pnas.0710685105","volume":"105","author":"AD Gitler","year":"2008","unstructured":"Gitler AD, Bevis BJ, Shorter J, Strathearn KE, Hamamichi S, Su LJ, et al. The Parkinson\u2019s disease protein \u03b1-synuclein disrupts cellular Rab homeostasis. PNAS. 2008;105:145\u201350. https:\/\/doi.org\/10.1073\/pnas.0710685105.","journal-title":"PNAS"},{"key":"699_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3233\/jpd-202374","volume":"11","author":"FA Boros","year":"2021","unstructured":"Boros FA, V\u00e9csei L, Kliv\u00e9nyi P. NEAT1 on the field of Parkinson\u2019s disease: Offense, defense, or a player on the bench? J Parkinsons Dis. 2021;11:123\u201338. https:\/\/doi.org\/10.3233\/jpd-202374.","journal-title":"J Parkinsons Dis"},{"key":"699_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-023-00446-8","volume":"9","author":"LC Tranchevent","year":"2023","unstructured":"Tranchevent LC, Halder R, Glaab E. Systems level analysis of sex-dependent gene expression changes in Parkinson\u2019s disease. NPJ Parkinsons Dis. 2023;9:1\u201316. https:\/\/doi.org\/10.1038\/s41531-023-00446-8.","journal-title":"NPJ Parkinsons Dis"},{"key":"699_CR16","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.18632\/aging.101064","volume":"8","author":"A Pollard","year":"2016","unstructured":"Pollard A, Shephard F, Freed J, Liddell S, Chakrabarti L. Mitochondrial proteomic profiling reveals increased carbonic anhydrase II in aging and neurodegeneration. Aging (Albany NY). 2016;8:2425\u201336. https:\/\/doi.org\/10.18632\/aging.101064.","journal-title":"Aging (Albany NY)"},{"key":"699_CR17","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.neuron.2019.12.014","volume":"105","author":"HL Smith","year":"2020","unstructured":"Smith HL, Freeman OJ, Butcher AJ, Holmqvist S, Humoud I, Sch\u00e4tzl T, et al. Astrocyte unfolded protein response induces a specific reactivity state that causes non-cell-autonomous neuronal degeneration. Neuron. 2020;105:855-866.e5. https:\/\/doi.org\/10.1016\/j.neuron.2019.12.014.","journal-title":"Neuron"},{"key":"699_CR18","doi-asserted-by":"publisher","first-page":"12451","DOI":"10.18632\/oncotarget.14104","volume":"8","author":"V C\u00e1novas","year":"2017","unstructured":"C\u00e1novas V, Lleonart M, Morote J, Paciucci R. The role of prostate tumor overexpressed 1 in cancer progression. Oncotarget. 2017;8:12451\u201371. https:\/\/doi.org\/10.18632\/oncotarget.14104.","journal-title":"Oncotarget"},{"key":"699_CR19","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","volume":"24","author":"C Escartin","year":"2021","unstructured":"Escartin C, Galea E, Lakatos A, O\u2019Callaghan JP, Petzold GC, Serrano-Pozo A, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24:312\u201325. https:\/\/doi.org\/10.1038\/s41593-020-00783-4.","journal-title":"Nat Neurosci"},{"key":"699_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neulet.2012.05.048","volume":"520","author":"T Matsumoto","year":"2012","unstructured":"Matsumoto T, Imagama S, Hirano K, Ohgomori T, Natori T, Kobayashi K, et al. CD44 expression in astrocytes and microglia is associated with ALS progression in a mouse model. Neurosci Lett. 2012;520:115\u201320. https:\/\/doi.org\/10.1016\/j.neulet.2012.05.048.","journal-title":"Neurosci Lett"},{"key":"699_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40478-019-0735-1","volume":"7","author":"K Hartmann","year":"2019","unstructured":"Hartmann K, Sepulveda-Falla D, Rose IVL, Madore C, Muth C, Matschke J, et al. Complement 3+-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia. Acta Neuropathol Commun. 2019;7:83. https:\/\/doi.org\/10.1186\/s40478-019-0735-1.","journal-title":"Acta Neuropathol Commun"},{"key":"699_CR22","doi-asserted-by":"publisher","first-page":"E2987","DOI":"10.1073\/pnas.1320401111","volume":"111","author":"W Kang","year":"2014","unstructured":"Kang W, Balordi F, Su N, Chen L, Fishell G, H\u00e9bert JM. Astrocyte activation is suppressed in both normal and injured brain by FGF signaling. PNAS. 2014;111:E2987\u201395. https:\/\/doi.org\/10.1073\/pnas.1320401111.","journal-title":"PNAS"},{"key":"699_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1046\/j.1471-4159.2003.02004.x","volume":"87","author":"T Suuronen","year":"2003","unstructured":"Suuronen T, Huuskonen J, Pihlaja R, Kyrylenko S, Salminen A. Regulation of microglial inflammatory response by histone deacetylase inhibitors. J Neurochem. 2003;87:407\u201316. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.02004.x.","journal-title":"J Neurochem"},{"key":"699_CR24","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.3390\/ijms22041636","volume":"22","author":"A G\u00f3mez Morillas","year":"2021","unstructured":"G\u00f3mez Morillas A, Besson VC, Lerouet D. Microglia and neuroinflammation: what place for P2RY12? Int J Mol Sci. 2021;22:1636. https:\/\/doi.org\/10.3390\/ijms22041636.","journal-title":"Int J Mol Sci"},{"key":"699_CR25","doi-asserted-by":"publisher","first-page":"13421","DOI":"10.1074\/jbc.ra119.007645","volume":"294","author":"K Namekata","year":"2019","unstructured":"Namekata K, Guo X, Kimura A, Arai N, Harada C, Harada T. DOCK8 is expressed in microglia, and it regulates microglial activity during neurodegeneration in murine disease models. J Biol Chem. 2019;294:13421\u201333. https:\/\/doi.org\/10.1074\/jbc.ra119.007645.","journal-title":"J Biol Chem"},{"key":"699_CR26","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/ijms19030706","volume":"19","author":"T Z\u00f6ller","year":"2018","unstructured":"Z\u00f6ller T, Attaai A, Potru P, Ru\u00df T, Spittau B. Aged mouse cortical microglia display an activation profile suggesting immunotolerogenic functions. Int J Mol Sci. 2018;19:706. https:\/\/doi.org\/10.3390\/ijms19030706.","journal-title":"Int J Mol Sci"},{"key":"699_CR27","doi-asserted-by":"publisher","unstructured":"Bohush A, Le\u015bniak W, Weis S, Filipek A. Calmodulin and its binding proteins in Parkinson\u2019s disease. Int J Mol Sci. 2021;22:3016.\u00a0https:\/\/doi.org\/10.3390\/ijms22063016.","DOI":"10.3390\/ijms22063016"},{"key":"699_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-85510-0","volume":"11","author":"MC Bakeberg","year":"2021","unstructured":"Bakeberg MC, Hoes ME, Gorecki AM, Theunissen F, Pfaff AL, Kenna JE, et al. The TOMM40 \u2018523\u2019 polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson\u2019s disease. Sci Rep. 2021;11:1\u20139. https:\/\/doi.org\/10.1038\/s41598-021-85510-0.","journal-title":"Sci Rep"},{"key":"699_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-018-0143-7","volume":"8","author":"SZ Lu","year":"2019","unstructured":"Lu SZ, Guo YS, Liang PZ, Zhang SZ, Yin S, Yin YQ, et al. Suppression of astrocytic autophagy by \u03b1B-crystallin contributes to \u03b1-synuclein inclusion formation. Translational Neurodegeneration. 2019;8:1\u201314. https:\/\/doi.org\/10.1186\/s40035-018-0143-7.","journal-title":"Translational Neurodegeneration"},{"key":"699_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/b978-0-12-418700-9.00008-3","volume":"113","author":"BR Bill","year":"2013","unstructured":"Bill BR, Lowe JK, DyBuncio CT, Fogel BL. Orchestration of neurodevelopmental programs by RBFOX1: Implications for autism spectrum disorder. Int Rev Neurobiol. 2013;113:251\u201367. https:\/\/doi.org\/10.1016\/b978-0-12-418700-9.00008-3.","journal-title":"Int Rev Neurobiol"},{"key":"699_CR31","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat C, Nalls MA, Singleton AB. The genetic architecture of Parkinson\u2019s disease. Lancet Neurol. 2020;19:170\u20138. https:\/\/doi.org\/10.1016\/S1474-4422(19)30287-X.","journal-title":"Lancet Neurol"},{"key":"699_CR32","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18:1091\u2013102. https:\/\/doi.org\/10.1016\/S1474-4422(19)30320-5.","journal-title":"Lancet Neurol"},{"key":"699_CR33","doi-asserted-by":"publisher","first-page":"eabo2467","DOI":"10.1126\/sciadv.abo2467","volume":"9","author":"AJ Lee","year":"2023","unstructured":"Lee AJ, Kim C, Park S, Joo J, Choi B, Yang D, et al. Characterization of altered molecular mechanisms in Parkinson\u2019s disease through cell type\u2013resolved multiomics analyses. Sci Adv. 2023;9:eabo2467. https:\/\/doi.org\/10.1126\/sciadv.abo2467.","journal-title":"Sci Adv"},{"key":"699_CR34","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.4161\/auto.26448","volume":"9","author":"F Stricher","year":"2013","unstructured":"Stricher F, Macri C, Ruff M, Muller S. HSPA8\/HSC70 chaperone protein. Autophagy. 2013;9:1937\u201354. https:\/\/doi.org\/10.4161\/auto.26448.","journal-title":"Autophagy"},{"key":"699_CR35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/med.20052","volume":"26","author":"BSJ Blagg","year":"2006","unstructured":"Blagg BSJ, Kerr TD. Hsp90 inhibitors: small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation. Med Res Rev. 2006;26:310\u201338. https:\/\/doi.org\/10.1002\/med.20052.","journal-title":"Med Res Rev"},{"key":"699_CR36","doi-asserted-by":"publisher","first-page":"a005199","DOI":"10.1101\/cshperspect.a005199","volume":"3","author":"P Stanley","year":"2011","unstructured":"Stanley P. Golgi glycosylation. Cold Spring Harb Perspect Biol. 2011;3:a005199. https:\/\/doi.org\/10.1101\/cshperspect.a005199.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"699_CR37","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.3390\/ijms21238924","volume":"21","author":"SM Bell","year":"2020","unstructured":"Bell SM, Burgess T, Lee J, Blackburn DJ, Allen SP, Mortiboys H. Peripheral glycolysis in neurodegenerative diseases. Int J Mol Sci. 2020;21:8924. https:\/\/doi.org\/10.3390\/ijms21238924.","journal-title":"Int J Mol Sci"},{"key":"699_CR38","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nchem.2361","volume":"7","author":"NP Marotta","year":"2015","unstructured":"Marotta NP, Lin YH, Lewis YE, Ambroso MR, Zaro BW, Roth MT, et al. O-GlcNAc modification blocks the aggregation and toxicity of the protein \u03b1-synuclein associated with Parkinson\u2019s disease. Nat Chem. 2015;7:913\u201320. https:\/\/doi.org\/10.1038\/nchem.2361.","journal-title":"Nat Chem"},{"issue":"15","key":"699_CR39","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.3390\/nu14153240","volume":"14","author":"J Haas","year":"2022","unstructured":"Haas J, Berg D, Bosy-Westphal A, Schaeffer E. Parkinson\u2019s disease and sugar intake-reasons for and consequences of a still unclear craving. Nutrients. 2022;14:3240. https:\/\/doi.org\/10.3390\/nu14153240.","journal-title":"Nutrients"},{"key":"699_CR40","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3389\/fphar.2019.01294","volume":"10","author":"A Murueta-Goyena","year":"2019","unstructured":"Murueta-Goyena A, Andikoetxea A, G\u00f3mez-Esteban JC, Gabilondo I. Contribution of the GABAergic system to non-motor manifestations in premotor and early stages of Parkinson\u2019s disease. Front Pharmacol. 2019;10:1294. https:\/\/doi.org\/10.3389\/fphar.2019.01294.","journal-title":"Front Pharmacol"},{"key":"699_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-03802-y","volume":"9","author":"N Lozovaya","year":"2018","unstructured":"Lozovaya N, Eftekhari S, Cloarec R, Gouty-Colomer LA, Dufour A, Riffault B, et al. GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease. Nat Commun. 2018;9:1422.\u00a0https:\/\/doi.org\/10.1038\/s41467-018-03802-y.","journal-title":"Nat Commun"},{"key":"699_CR42","doi-asserted-by":"publisher","first-page":"16084","DOI":"10.1038\/srep16084","volume":"5","author":"R Hajj","year":"2015","unstructured":"Hajj R, Milet A, Toulorge D, Cholet N, Laffaire J, Foucquier J, et al. Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson\u2019s disease. Sci Rep. 2015;5:16084. https:\/\/doi.org\/10.1038\/srep16084.","journal-title":"Sci Rep"},{"key":"699_CR43","doi-asserted-by":"publisher","unstructured":"Giehrl-Schwab J, Giesert F, Rauser B, Lao CL, Hembach S, Lefort S, et al. Parkinson\u2019s disease motor symptoms rescue by CRISPRa-reprogramming astrocytes into GABAergic neurons. EMBO Mol Med. 2022;14:e14797.\u00a0https:\/\/doi.org\/10.15252\/emmm.202114797.","DOI":"10.15252\/emmm.202114797"},{"key":"699_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2020.146672","volume":"1730","author":"FA Boros","year":"2020","unstructured":"Boros FA, Maszlag-T\u00f6r\u00f6k R, V\u00e9csei L, Kliv\u00e9nyi P. Increased level of NEAT1 long non-coding RNA is detectable in peripheral blood cells of patients with Parkinson\u2019s disease. Brain Res. 2020;1730:146672. https:\/\/doi.org\/10.1016\/j.brainres.2020.146672.","journal-title":"Brain Res"},{"key":"699_CR45","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/abbs\/gmab055","volume":"53","author":"LI Dong","year":"2021","unstructured":"Dong LI, Zheng Y, Gao L, Luo X. lncRNA NEAT1 prompts autophagy and apoptosis in MPTP-induced Parkinson\u2019s disease by impairing miR-374c-5p. Acta Biochim Biophys Sin. 2021;53:870\u201382. https:\/\/doi.org\/10.1093\/abbs\/gmab055.","journal-title":"Acta Biochim Biophys Sin"},{"key":"699_CR46","doi-asserted-by":"publisher","first-page":"11223","DOI":"10.1096\/fj.201900830r","volume":"33","author":"A Simchovitz","year":"2019","unstructured":"Simchovitz A, Hanan M, Niederhoffer N, Madrer N, Yayon N, Bennett ER, et al. NEAT1 is overexpressed in Parkinson\u2019s disease substantia nigra and confers drug-inducible neuroprotection from oxidative stress. FASEB J. 2019;33:11223\u201334. https:\/\/doi.org\/10.1096\/fj.201900830r.","journal-title":"FASEB J"},{"key":"699_CR47","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2147\/jir.s338162","volume":"15","author":"Y Pan","year":"2022","unstructured":"Pan Y, Wang T, Zhao Z, Wei W, Xin W, Yang X, et al. Novel insights into the emerging role of Neat1 and its effects downstream in the regulation of inflammation. J Inflamm Res. 2022;15:557\u201371. https:\/\/doi.org\/10.2147\/jir.s338162.","journal-title":"J Inflamm Res"},{"issue":"8","key":"699_CR48","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/antiox8080265","volume":"8","author":"A Rizor","year":"2019","unstructured":"Rizor A, Pajarillo E, Johnson J, Aschner M, Lee E. Astrocytic oxidative\/nitrosative stress contributes to Parkinson\u2019s disease pathogenesis: The dual role of reactive astrocytes. Antioxidants. 2019;8:265. https:\/\/doi.org\/10.3390\/antiox8080265.","journal-title":"Antioxidants"},{"key":"699_CR49","doi-asserted-by":"publisher","unstructured":"Chen Y, Qin C, Huang J, Tang X, Liu C, Huang K, et al. The role of astrocytes in oxidative stress of central nervous system: A mixed blessing. Cell Prolif. 2020;53:e12781.\u00a0https:\/\/doi.org\/10.1111\/cpr.12781.","DOI":"10.1111\/cpr.12781"},{"key":"699_CR50","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10048-011-0294-5","volume":"12","author":"GJ Michael","year":"2011","unstructured":"Michael GJ, Esmailzadeh S, Moran LB, Christian L, Pearce RKB, Graeber MB. Up-regulation of metallothionein gene expression in Parkinsonian astrocytes. Neurogenetics. 2011;12:295\u2013305. https:\/\/doi.org\/10.1007\/s10048-011-0294-5.","journal-title":"Neurogenetics"},{"key":"699_CR51","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/MDS.27037","volume":"32","author":"TJ Collier","year":"2017","unstructured":"Collier TJ, Kanaan NM, Kordower JH. Aging and Parkinson\u2019s disease: different sides of the same coin? Mov Disord. 2017;32:983\u201390. https:\/\/doi.org\/10.1002\/MDS.27037.","journal-title":"Mov Disord"},{"key":"699_CR52","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, et al. Aggregated \u03b1-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. FASEB J. 2005;19:533\u201342. https:\/\/doi.org\/10.1096\/fj.04-2751com.","journal-title":"FASEB J"},{"key":"699_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep30805","volume":"6","author":"N Hamada","year":"2016","unstructured":"Hamada N, Ito H, Nishijo T, Iwamoto I, Morishita R, Tabata H, et al. Essential role of the nuclear isoform of RBFOX1, a candidate gene for autism spectrum disorders, in the brain development. Sci Rep. 2016;6:1\u201319. https:\/\/doi.org\/10.1038\/srep30805.","journal-title":"Sci Rep"},{"key":"699_CR54","doi-asserted-by":"publisher","unstructured":"Lin L, G\u00f6ke J, Cukuroglu E, Dranias MR, VanDongen AMJ, Stanton LW. Molecular features underlying neurodegeneration identified through in vitro modeling of genetically diverse Parkinson\u2019s disease patients. Cell Rep. 2016;15:2411\u201326. https:\/\/doi.org\/10.1016\/j.celrep.2016.05.022.","DOI":"10.1016\/j.celrep.2016.05.022"},{"key":"699_CR55","doi-asserted-by":"publisher","unstructured":"Tornatore C, Baker-Cairns B, Yadid G, Hamilton R, Meyers K, Atwood W, et al. Expression of tyrosine hydroxylase in an immortalized human fetal astrocyte cell line; in vitro characterization and engraftment into the rodent striatum. Cell Transplant. 1996;5:145\u201363. https:\/\/doi.org\/10.1177\/096368979600500206.","DOI":"10.1177\/096368979600500206"},{"key":"699_CR56","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/sj.gt.3300776","volume":"5","author":"J Segovia","year":"1998","unstructured":"Segovia J, Vergara P, Brenner M. Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental Parkinsonism. Gene Ther. 1998;5:1650\u20135. https:\/\/doi.org\/10.1038\/sj.gt.3300776.","journal-title":"Gene Ther"},{"key":"699_CR57","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11481-019-09851-4","volume":"15","author":"SM Matt","year":"2020","unstructured":"Matt SM, Gaskill PJ. Where is dopamine and how do immune cells see it?: Dopamine-mediated immune cell function in health and disease. J Neuroimmune Pharmacol. 2020;15:114\u201364. https:\/\/doi.org\/10.1007\/s11481-019-09851-4.","journal-title":"J Neuroimmune Pharmacol"},{"key":"699_CR58","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.neurobiolaging.2008.01.001","volume":"30","author":"D Mastroeni","year":"2009","unstructured":"Mastroeni D, Grover A, Leonard B, Joyce JN, Coleman PD, Kozik B, et al. Microglial responses to dopamine in a cell culture model of Parkinson\u2019s disease. Neurobiol Aging. 2009;30:1805\u201317. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.01.001.","journal-title":"Neurobiol Aging"},{"key":"699_CR59","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41380-018-0226-y","volume":"25","author":"F Petrelli","year":"2018","unstructured":"Petrelli F, Dall\u00e9rac G, Pucci L, Cal\u00ec C, Zehnder T, Sultan S, et al. Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments. Mol Psychiatry. 2018;25:732\u201349. https:\/\/doi.org\/10.1038\/s41380-018-0226-y.","journal-title":"Mol Psychiatry"},{"key":"699_CR60","doi-asserted-by":"publisher","first-page":"6568","DOI":"10.3390\/ijms22126568","volume":"22","author":"S Takahashi","year":"2021","unstructured":"Takahashi S, Koizumi S. Neuroprotective function of high glycolytic activity in astrocytes: common roles in stroke and neurodegenerative diseases. Int J Mol Sci. 2021;22:6568. https:\/\/doi.org\/10.3390\/ijms22126568.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"699_CR61","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12974-022-02410-4","volume":"19","author":"AF Pike","year":"2022","unstructured":"Pike AF, Longhena F, Faustini G, van Eik JM, Gombert I, Herrebout MAC, et al. Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson\u2019s disease. J Neuroinflammation. 2022;19:50. https:\/\/doi.org\/10.1186\/s12974-022-02410-4.","journal-title":"J Neuroinflammation"},{"key":"699_CR62","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1126\/science.aad7038","volume":"353","author":"N Habib","year":"2016","unstructured":"Habib N, Li Y, Heidenreich M, Swiech L, Avraham-Davidi I, Trombetta JJ, et al. Div-Seq: Single-nucleus RNA-Seq reveals dynamics of rare adult newborn neurons. Science. 2016;353:925\u20138. https:\/\/doi.org\/10.1126\/science.aad7038.","journal-title":"Science"},{"key":"699_CR63","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","volume":"8","author":"SL Wolock","year":"2019","unstructured":"Wolock SL, Lopez R, Klein AM. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 2019;8:281-291.e9. https:\/\/doi.org\/10.1016\/j.cels.2018.11.005.","journal-title":"Cell Syst"},{"key":"699_CR64","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, et al. Comprehensive integration of single-cell data. Cell. 2019;177:1888-1902.e21. https:\/\/doi.org\/10.1016\/j.cell.2019.05.031.","journal-title":"Cell"},{"key":"699_CR65","doi-asserted-by":"publisher","first-page":"e1004219","DOI":"10.1371\/journal.pcbi.1004219","volume":"11","author":"CA de Leeuw","year":"2015","unstructured":"de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol. 2015;11:e1004219. https:\/\/doi.org\/10.1371\/journal.pcbi.1004219.","journal-title":"PLoS Comput Biol"},{"key":"699_CR66","doi-asserted-by":"publisher","unstructured":"Reynolds RH, Bot\u00eda J, Nalls MA, International Parkinson\u2019s Disease Genomics Consortium (IPDGC), System Genomics of Parkinson\u2019s Disease (SGPD), Hardy J, et al. Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson\u2019s disease heritability. NPJ Parkinsons Dis 2019;5:6. https:\/\/doi.org\/10.1038\/s41531-019-0076-6.","DOI":"10.1038\/s41531-019-0076-6"},{"key":"699_CR67","doi-asserted-by":"publisher","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Cambridge (Mass)). 2021;2:100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141.","DOI":"10.1016\/j.xinn.2021.100141"},{"key":"699_CR68","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6.","journal-title":"Nat Commun"},{"key":"699_CR69","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41587-021-01044-w","volume":"40","author":"V Petukhov","year":"2022","unstructured":"Petukhov V, Xu RJ, Soldatov RA, Cadinu P, Khodosevich K, Moffitt JR, et al. Cell segmentation in imaging-based spatial transcriptomics. Nat Biotechnol. 2022;40:345\u201354. https:\/\/doi.org\/10.1038\/s41587-021-01044-w.","journal-title":"Nat Biotechnol"}],"updated-by":[{"DOI":"10.1186\/s13024-024-00717-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000}}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-023-00699-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-023-00699-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-023-00699-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T09:04:34Z","timestamp":1711357474000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-023-00699-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,20]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["699"],"URL":"https:\/\/doi.org\/10.1186\/s13024-023-00699-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.01.04.522691","asserted-by":"object"}]},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,20]]},"assertion":[{"value":"16 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13024-024-00717-9","URL":"https:\/\/doi.org\/10.1186\/s13024-024-00717-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of UZ Leuven\/KU Leuven approved the use of human samples and gave ethical approval in line with the relevant Belgian legislation on privacy. Samples used in this study are registered in the UZ Leuven Biobank under the S-number S64182. Further details are available at","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"T.G.B. is CEO of The Bioinformatics CRO and Senior Director of Bioinformatics at Bit.Bio. D.R.T. has received various honoraria related to speaking engagements from Biogen (USA) and UCB (Brussels, Belgium), and benefited from research collaborations with Novartis Pharma AG (Basel, Switzerland), Probiodrug (Halle (Saale), Germany), GE Healthcare (Amersham, UK), and Janssen Pharmaceuticals (Beerse, Belgium). \u200bE.M. is an employee and shareholder of Bit.Bio. M.G.H. acted as a paid consultant to Resolve Biosciences during development of their Molecular Cartography system.\u00a0A.M. is currently an employee at Muna Therapeutics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}